119 related articles for article (PubMed ID: 17140370)
21. Simultaneous monitoring by real-time polymerase chain reaction of epstein-barr virus, human cytomegalovirus, and human herpesvirus-6 in juvenile and adult liver transplant recipients.
Ono Y; Ito Y; Kaneko K; Shibata-Watanabe Y; Tainaka T; Sumida W; Nakamura T; Kamei H; Kiuchi T; Ando H; Kimura H
Transplant Proc; 2008 Dec; 40(10):3578-82. PubMed ID: 19100443
[TBL] [Abstract][Full Text] [Related]
22. Rapid quantitative PCR assays for the simultaneous detection of herpes simplex virus, varicella zoster virus, cytomegalovirus, Epstein-Barr virus, and human herpesvirus 6 DNA in blood and other clinical specimens.
Engelmann I; Petzold DR; Kosinska A; Hepkema BG; Schulz TF; Heim A
J Med Virol; 2008 Mar; 80(3):467-77. PubMed ID: 18205230
[TBL] [Abstract][Full Text] [Related]
23. Cell death in hematological tumors.
Fulda S
Apoptosis; 2009 Apr; 14(4):409-23. PubMed ID: 19130230
[TBL] [Abstract][Full Text] [Related]
24. Immune activation suppresses initiation of lytic Epstein-Barr virus infection.
Ladell K; Dorner M; Zauner L; Berger C; Zucol F; Bernasconi M; Niggli FK; Speck RF; Nadal D
Cell Microbiol; 2007 Aug; 9(8):2055-69. PubMed ID: 17419714
[TBL] [Abstract][Full Text] [Related]
25. A molecular link between malaria and Epstein-Barr virus reactivation.
Chêne A; Donati D; Guerreiro-Cacais AO; Levitsky V; Chen Q; Falk KI; Orem J; Kironde F; Wahlgren M; Bejarano MT
PLoS Pathog; 2007 Jun; 3(6):e80. PubMed ID: 17559303
[TBL] [Abstract][Full Text] [Related]
26. Clinical usefulness of serum EBV DNA levels of BamHI W and LMP1 for Nasal NK/T-cell lymphoma.
Ishii H; Ogino T; Berger C; Köchli-Schmitz N; Nagato T; Takahara M; Nadal D; Harabuchi Y
J Med Virol; 2007 May; 79(5):562-72. PubMed ID: 17385697
[TBL] [Abstract][Full Text] [Related]
27. A novel, noninvasive diagnostic probe for hydroa vacciniforme and related disorders: detection of latency-associated Epstein-Barr virus transcripts in the crusts.
Yamamoto T; Tsuji K; Suzuki D; Morizane S; Iwatsuki K
J Microbiol Methods; 2007 Feb; 68(2):403-7. PubMed ID: 17141343
[TBL] [Abstract][Full Text] [Related]
28. Targeting CTCF to Control Virus Gene Expression: A Common Theme amongst Diverse DNA Viruses.
Pentland I; Parish JL
Viruses; 2015 Jul; 7(7):3574-85. PubMed ID: 26154016
[TBL] [Abstract][Full Text] [Related]
29. Quantitative detection of herpes simplex virus DNA in the lower respiratory tract.
Gooskens J; Templeton KE; Claas EC; van Bussel MJ; Smit VT; Kroes AC
J Med Virol; 2007 May; 79(5):597-604. PubMed ID: 17385683
[TBL] [Abstract][Full Text] [Related]
30. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome.
de Pagter PJ; Schuurman R; Visscher H; de Vos M; Bierings M; van Loon AM; Uiterwaal CS; van Baarle D; Sanders EA; Boelens J
Biol Blood Marrow Transplant; 2008 Jul; 14(7):831-9. PubMed ID: 18541204
[TBL] [Abstract][Full Text] [Related]
31. Quantitative PCR for Epstein-Barr virus DNA and RNA in multiple sclerosis.
Lindsey JW; Hatfield LM; Crawford MP; Patel S
Mult Scler; 2009 Feb; 15(2):153-8. PubMed ID: 18845656
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus-DNA load monitoring late after lung transplantation: a surrogate marker of the degree of immunosuppression and a safe guide to reduce immunosuppression.
Bakker NA; Verschuuren EA; Erasmus ME; Hepkema BG; Veeger NJ; Kallenberg CG; van der Bij W
Transplantation; 2007 Feb; 83(4):433-8. PubMed ID: 17318076
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus-associated epithelial and mesenchymal neoplasms.
Deyrup AT
Hum Pathol; 2008 Apr; 39(4):473-83. PubMed ID: 18342658
[TBL] [Abstract][Full Text] [Related]
34. Sustained Epstein-Barr virus detection in paediatric liver transplantation. Insights into the occurrence of late PTLD.
D'Antiga L; Del Rizzo M; Mengoli C; Cillo U; Guariso G; Zancan L
Liver Transpl; 2007 Mar; 13(3):343-8. PubMed ID: 17154402
[TBL] [Abstract][Full Text] [Related]
35. EBV-associated lymphoproliferative disorders: classification and treatment.
Carbone A; Gloghini A; Dotti G
Oncologist; 2008 May; 13(5):577-85. PubMed ID: 18515742
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus prevalence in oral squamous cell cancer and in potentially malignant oral disorders in an eastern Hungarian population.
Kis A; Fehér E; Gáll T; Tar I; Boda R; Tóth ED; Méhes G; Gergely L; Szarka K
Eur J Oral Sci; 2009 Oct; 117(5):536-40. PubMed ID: 19758249
[TBL] [Abstract][Full Text] [Related]
37. Management of viral hepatitis in hematologic malignancies.
Firpi RJ; Nelson DR
Blood Rev; 2008 May; 22(3):117-26. PubMed ID: 18343002
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus in autoimmune diseases.
Toussirot E; Roudier J
Best Pract Res Clin Rheumatol; 2008 Oct; 22(5):883-96. PubMed ID: 19028369
[TBL] [Abstract][Full Text] [Related]
39. Lytic cycle switches of oncogenic human gammaherpesviruses.
Miller G; El-Guindy A; Countryman J; Ye J; Gradoville L
Adv Cancer Res; 2007; 97():81-109. PubMed ID: 17419942
[TBL] [Abstract][Full Text] [Related]
40. DNA tumor viruses and human cancer.
Damania B
Trends Microbiol; 2007 Jan; 15(1):38-44. PubMed ID: 17113775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
